EULAV Asset Management’s Medtronic MDT Stock Holding History

EULAV Asset Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-30,000	Closed	-$2.42M	–	294
2017 Q4	$2.42M	Sell	30,000 -4,000	-12%	-$320K	0.11%	182
2017 Q3	$2.64M	Sell	34,000 -1,000	-3%	-$83K	0.12%	183
2017 Q2	$3.11M	Sell	35,000 -15,000	-30%	-$1.26M	0.15%	172
2017 Q1	$4.03M	Sell	50,000 -1,000	-2%	-$78.1K	0.21%	153
2016 Q4	$3.63M	Sell	51,000 -15,000	-23%	-$1.18M	0.2%	163
2016 Q3	$5.7M	Sell	66,000 -3,000	-4%	-$261K	0.3%	120
2016 Q2	$5.99M	Buy	69,000 +1,000	+1%	+$80.9K	0.33%	107
2016 Q1	$5.1M	Buy	68,000 +2,000	+3%	+$151K	0.28%	129
2015 Q4	$5.08M	Sell	66,000 -9,000	-12%	-$677K	0.28%	126
2015 Q3	$5.02M	Buy	75,000 +2,000	+3%	+$147K	0.29%	126
2015 Q2	$5.41M	Buy	73,000 +9,000	+14%	+$688K	0.28%	128
2015 Q1	$4.99M	Buy	64,000 +6,000	+10%	+$455K	0.26%	139
2014 Q4	$4.19M	Buy	58,000 +5,000	+9%	+$347K	0.23%	152
2014 Q3	$3.28M	Buy	53,000 +25,000	+89%	+$1.59M	0.18%	184
2014 Q2	$1.78M	Buy	+28,000	New	+$1.7M	0.1%	269

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

EULAV Asset Management's MDT Position: Q1 2018 in Review

EULAV Asset Management sold out of Medtronic (MDT) in Q1 2018, closing a stake of 30,000 shares — an estimated $2.42M sold.

EULAV Asset Management first reported a position in MDT in Q2 2014 and held it in 15 quarters. The position peaked at $5.99M in Q2 2016. 1,381 funds tracked by Wall St. Rank hold MDT as of Q1 2018.

EULAV Asset Management reported no remaining Medtronic position as of Q1 2018 after selling out during the quarter.
EULAV Asset Management sold 30,000 Medtronic shares in Q1 2018, an estimated $2.42M.
EULAV Asset Management first reported a position in Medtronic in Q2 2014 and held it in 15 quarters.
EULAV Asset Management's Medtronic position peaked at $5.99M in Q2 2016.
1,381 funds tracked by Wall St. Rank held Medtronic as of Q1 2018.

Based on EULAV Asset Management's 13F filing for Q1 2018, filed 9 May 2018.